Conditions: Rhinitis, Allergic, Seasonal Asthma
Keywords: Seasonal Allergic Rhinitis Asthma
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 188
Healthy volunteers: no

Brief summary:
This study will compare mometasone nasal spray to placebo in treating the nasal and asthma symptoms experienced by participants with seasonal allergic rhinitis (SAR) and concomitant asthma.

Detailed description:

Arms:
arm 1: Mometasone nasal spray 200 mcg, administered once daily (QD) for 4 weeks arm 2: Matching placebo nasal spray, administered QD for 4 weeks

Interventions: intervention 1: Mometasone intervention 2: Placebo intervention 3: Albuterol/Salbutamol
Intervention descriptions: intervention 1: Mometasone nasal spray 200 mcg/day administered as 2 sprays (50 mcg/spray) in each nostril. intervention 2: Matching placebo nasal spray, administered QD as 2 sprays in each nostril. intervention 3: Albuterol/salbutamol metered dose inhaler (90 mcg/puff) used as needed as asthma rescue medication.

Protocol document: